PRMT5 inhibition disrupts splicing and stemness in glioblastoma
Open Access
- 12 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 12 (1), 1-17
- https://doi.org/10.1038/s41467-021-21204-5
Abstract
Glioblastoma (GBM) is a deadly cancer in which cancer stem cells (CSCs) sustain tumor growth and contribute to therapeutic resistance. Protein arginine methyltransferase 5 (PRMT5) has recently emerged as a promising target in GBM. Using two orthogonal-acting inhibitors of PRMT5 (GSK591 or LLY-283), we show that pharmacological inhibition of PRMT5 suppresses the growth of a cohort of 46 patient-derived GBM stem cell cultures, with the proneural subtype showing greater sensitivity. We show that PRMT5 inhibition causes widespread disruption of splicing across the transcriptome, particularly affecting cell cycle gene products. We identify a GBM splicing signature that correlates with the degree of response to PRMT5 inhibition. Importantly, we demonstrate that LLY-283 is brain-penetrant and significantly prolongs the survival of mice with orthotopic patient-derived xenografts. Collectively, our findings provide a rationale for the clinical development of brain penetrant PRMT5 inhibitors as treatment for GBM.Keywords
Funding Information
- Entertainment Industry Foundation (SU2C-AACR-DT-19-15)
This publication has 78 references indexed in Scilit:
- Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamicsProceedings of the National Academy of Sciences of the United States of America, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- The sva package for removing batch effects and other unwanted variation in high-throughput experimentsBioinformatics, 2012
- Versatility of PRMT5-induced methylation in growth control and developmentTrends in Biochemical Sciences, 2011
- Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature reviewInternational Journal of Cancer, 2010
- Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genesNature, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Characterization of a Novel Cardiac Isoform of the Cell Cycle-related Kinase That Is Regulated during Heart FailureOnline Journal of Public Health Informatics, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006